BPC-157 TikTok claims: what the science actually supports

What did @growthovereverything actually say?

The creator made a few distinct arguments: that BPC-157 is widely used by combat athletes for injury recovery, that it "works really well" for healing, that UFC tests for it while Jiu-Jitsu does not, and that sports organizations should distinguish between performance-enhancing drugs and healing aids. They used Gordon Ryan as an example of an athlete with access to peptide protocols that most UFC fighters supposedly lack.

The framing was casual and conversational, but the underlying claims are worth pulling apart. Some hold up reasonably well. Others are doing more work than the evidence supports.

Does the science back this up?

Partly, but the gap between animal data and human clinical evidence is large enough to matter. Most of the existing research on BPC-157 involves rodent models, and the results there are genuinely interesting.

Studies in rats have shown BPC-157 accelerates tendon-to-bone healing, reduces inflammation in muscle tissue, and promotes angiogenesis at injury sites. Chang et al. (2011, Journal of Applied Physiology) found improved tendon healing in a rat Achilles model. Sikiric et al. (2018, Current Pharmaceutical Design) reviewed gastrointestinal and systemic protective effects, noting BPC-157 appears to modulate nitric oxide pathways.

The problem is that none of this has been replicated in randomized controlled trials in humans. There are no published Phase II or Phase III trials for musculoskeletal injury in athletes. The creator says it "works really well" as if this is settled. It is not settled. It is promising and unverified in humans.

What did they get wrong (or right)?

They got the general landscape of use right: BPC-157 is genuinely popular among combat athletes, and anecdotal reports of faster recovery are widespread. The claim that UFC athletes face testing while grappling competitors largely do not is also broadly accurate based on available anti-doping policies.

Where the creator overshoots is in certainty. Saying it "works really well" without acknowledging zero human RCT data is misleading by omission. The comparison between Gordon Ryan's access to peptide protocols and a UFC fighter's restricted access is also speculative. We do not know what specific compounds Ryan uses, and the implication that BPC-157 is the variable responsible for faster recovery ignores confounders like training load, medical staff quality, and rest.

The creator also conflates BPC-157 with broader peptide stacks, which is worth flagging. Lumping all healing peptides together as benign recovery tools glosses over the fact that different peptides carry different risk profiles and regulatory statuses.

What should you actually know?

BPC-157 is not FDA-approved for any indication. It is available in the U.S. primarily through compounding pharmacies, and the FDA issued a notice in 2023 removing it from the list of bulk drug substances eligible for compounding, citing insufficient evidence of safety and effectiveness for any condition.

That does not mean it is dangerous. It means it has not cleared the evidentiary bar that approved drugs have cleared. That is a meaningful distinction.

If you are an athlete considering BPC-157, the relevant questions are: what governing body covers your sport, what does their prohibited list say, and have you spoken with a physician who understands both the pharmacology and the regulatory environment? The anti-doping picture is also less clear than the creator suggests. WADA does not currently list BPC-157 on its prohibited list, but individual sports organizations can and do set their own rules. Assuming it is safe to use in competition without checking your specific federation's policy is a mistake.

The creator's broader point, that sports medicine should separate performance enhancement from injury recovery, is a legitimate philosophical debate in sports ethics. It is just not as simple as they make it sound.